HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2019 Issues

Cover

Vol. 21 • No. N1 • February 2019

In this issue:

  • Improving Response Capacities in Opioid Overdose Management
    Cozzolino E., D'Egidio P.F., De Facci R., Leonardi C., Nava F., Stella L., and Maremmani I.
  • An Analysis of Psychological and Physical Problems Faced by Drug (Barsh) Addicts in Khyber Pakhtunkhwa, Pakistan
    Jan S.U.K., and Ali A.
  • Practitioners' Experiences of Working with Dual Users of Heroin and Crack Cocaine. A Thematic Analysis
    Heidebrecht F., and Macleod M.B.
  • Early Maladjustment Schemas in Opioid Abstainers, Opioid Abusers and Normal Individuals
    Veiskarami H.A., Mirdrikvand F., Khodarahimi S., and Rahmian Bougar M.
  • Hepatitis C Virus (Hcv) Screening in People Who Inject Drugs (Pwid) and Prisoners - a Narrative Review of Extant Literature
    Crowley D., Cullen W., Lambert J., and Van Hout M.C.
  • How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 6: psychosocial Care
    Ulmer A., and Meinhold C.

 

Cover

Vol. 21 • No. N2 • April 2019

In this issue:

  • Hepatitis C Treatment and Prevention in Pwid and Prisoners: A Narrative Review of the Extant Literature.
    Crowley D., Cullen W., Lambert J., and Van Hout M.C.
  • Over the Counter (Otc) Analgesic Misuse: One Patient's Journey
    Hill D., and Stewart E.
  • Early Age of First Drug Misuse Is Associated with Increased Risk of Suicide Attempt by Overdose Amongst Patients with Heroin Addiction in Medication-Assisted Treatment Programmes
    Kastelic A., Pregelj P., Zaman R., and Segrec N.
  • Hepatitis C Screening in Inpatient Addiction Treatment Settings in Istanbul Turkey: Implications for Integrating Treatment Services
    Alaei A., Mishkin K., Alaei K., Bilici R., Altintas M., and Altice F.
  • Surviving in the Workplace: Conditions in Centres for the Prevention and Treatment of Drug Addiction
    Ignjatova L.
  • Does Impulsivity Increase the Risk of Developing a Pathological Condition?
    Conversano C., Marchi L., Ciacchini R., Bertolucci I., Micheloni T., and Maremmani A.G.I.

 

Cover

Vol. 21 • No. N3 • June 2019

In this issue:

  • Relationship between Syringe Sharing and Severity of Psychopathology, Antisocial Personality Disorder and Novelty Seeking in a Sample of Patients with Heroin Use Disorder
    Alnıak İ., Karabulut V., Evren C., Çetin T., Umut G., Ağaçhanlı R., and Evren B.
  • Self-Reported Adverse Experiences and Age of Opioid Onset for First Time Admitted to Opioid Maintenance Treatment
    Carlsen S.-E.L., and Torsheim T.
  • Using Medication Assisted Treatment to Treat Opioid Use Disorder: Learning from Past Experience to Guide Policy
    Parrino M.
  • Low Mindfulness Trait Associated with High Perceived Stress Equally by Methadone Maintenance Treatment Patients and Medical Students
    Claman A., Adelson M., Sason A., Barkay G., and Peles E.
  • Difficulties in Initiating Hepatitis C Treatment in Patients with Opioid Use Disorder: Patient's Perspective
    Palma-Alvarez R.F., Ros-Cucurull E., Grau-López L., Martínez-Luna N., Rodríguez-Cintas L., Álvarez A.I., and Roncero C.
  • Towards a Specific Psychopathology of Substance Use Disorder: Comparison between Heroin Use Disorder and Chronic Psychotic Patients
    Rugani F., Paganin W., Maremmani A.G.I., Perugi G., and Maremmani I.

 

Cover

Vol. 21 • No. N4 • August 2019

In this issue:

  • Association of Drd2 Gene Polymorphism with Heroin Dependence.
    Koijam A.S., and Haobam R.
  • The Effect of Heroin, Cannabis and Cocaine Addiction on Sexual Functions and Depression of Women: A Comparative Cross-Sectional Study
    Dişsiz M.
  • Risk of Hepatitis C Virus Infection among Heroin and Methamphetamine Users
    Okruhlica L., and Kamendy Z.
  • Cross-Sectional Study on the Need to Provide Contraceptive Services to Women Attending Opioid-Substitution Therapy
    Olioff J., O Shea T., Horan A., Naughton A.M., and O'Brien D.
  • Ethnicity and Specific Psychopathology of Addiction. Comparison between Slovenian and Italian Heroin Use Disorder Patients
    Maremmani A.G.I., Lovrecic M., Lovrecic B., and Maremmani I.
  • Additional Comments to Staub Et Al., “How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting”
    Muller A.E., and Roessler K.K.

 

Cover

Vol. 21 • No. N5 • October 2019

In this issue:

  • The European Medical Agency and the Unfolding Destiny of Alcohol Use Disorder Patients
    Maremmani I.
  • Toward Diagnostic and Therapeutic Relativism in Psychiatry and Addiction Medicine
    Mendelevich V.
  • A Systematic Review of Methadone Maintenance Therapy Studies in Preventing Relapses in Addiction: Evidence from Asean Countries
    Mohd Fahami N.A., Nazrun Shuid A., Abdullah A., Naina-Mohamed I., Chin K.-Y., Mohamed N., Masbah N., Haji Mohd Saad Q., Kamisah Y., and Muhammad N.
  • The Impact of Mindfulness-Based Relapse Prevention on Craving, Lapse and Mindfulness Fostering in Addicted Patients in Methadone Maintenance Treatment
    Sarami Foroushani N.
  • Cardiological Safety in Patients Receiving Methadone Treatment
    Farina G., Mungai F., and Starace F.
  • How Probation Affects Treatment of Opioid Use Disorders: Comparison of Early Remission Rates between Opioid Use Disorder Patients Admitted to Medical Clinic Voluntarily and by Probation
    Asan Ö., Şahiner İ.V., Şahiner Ş.Y., and Göka E.
  • Ethnicity and Specific Psychopathology of Addiction. Comparison between Migrant and Italian Heroin Use Disorder Patients
    Carbone M.G., Tagliarini C., Ricci M., Lupi A.M., Sarandrea L., Ceban A., Casella P., and Maremmani I.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page